Coelho MLN, Saldanha L, Auad H, Castro ME, Fraga R. GLP-1 RECEPTOR AGONISTS AND SGLT-2 INHIBITORS BEYOND GLYCEMIC CONTROL: CARDIOVASCULAR BENEFITS IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS. REASE [Internet]. 2025 Oct. 14 [cited 2026 Sep. 28];11(10):2102-10. Available from: https://periodicorease.pro.br/rease/article/view/21484